Pangali rega marang bathi bionanogenomics.com (BNGO)

Bionano - logo grafis emiten BNGO

Geopolitical instability and sanctions are severely hindering the global sales of DNA analysis systems and international scientific exchange. The market dynamics of Bionano Genomics, Inc. (BNGO) securities reflect a PE ratio of -0.50. Exclusive patents and US support serve as a business defense, although stringent FDA oversight complicates operations. Meanwhile, the company suffers from a liquidity shortage and high operating expenses.

Bionano Genomics (BNGO): Rasio rega marang bathi saka 04.07.2022 nganti 16.11.2026

Rincian analitis perusahaan bionanogenomics.com (BNGO)

- rega pasar lan target rega analis:
Ringkesan analisis perusahaan:BNGO - Bionano Genomics
Produk asli Bionano Genomics, Inc.

P/E measures the market value of a single unit of net profit, determining the payback period for investments. For Bionano Genomics, Inc. (BNGO), this calculation depends on operating margins during the assembly of complex genome mapping systems. The current P/E of the business is -0.50, reflecting market expectations regarding growth rates. The dynamics of this value help assess the risk of overpayment against the backdrop of logistics costs. It is critical for the investor to compare this ratio with the asset's liquidity.

Pesaing wigati

tempus.com - Kapitalisasi marang bathi resik|Pangali P/E QGEN|Periode bali modal bisnis Isis Pharmaceuticals|Pangali P/E RGEN (repligen.com)|Rasio rega pasar marang bathi resik RNA (Avidity Biosciences, Inc.)|CRSP - Rasio rega marang bathi|Nilai perusahaan marang bathi resik WGS (GeneDx)|RARE: Pangali P/E|Beam Therapeutics Corp - Nilai perusahaan marang bathi resik|Koefisien rega marang bathi SRPT|twistbioscience.com (TWST) - Periode bali modal bisnis|Pangali P/E TXG|NTLA (Intellia) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Stoke STOK|BioLife (BLFS) - Kapitalisasi marang bathi|wavelifesciences.com - Pangali P/E|Kapitalisasi marang bathi resik MAZE|SION: Pangali P/E|PRME - Periode bali modal bisnis|Koefisien rega marang bathi TSHA|QURE - Rasio kapitalisasi marang bathi resik|Pangali P/E MGTX|Periode bali modal bisnis regenxbio.com|Pangali P/E SLDB (Solid Biosciences Inc)|OCGN: Pangali rega marang bathi|PACB - Rasio rega marang bathi|Benitec (BNTC) - Koefisien rega marang bathi|DSGN: Pangali P/E|RCKT: Rasio rega pasar marang bathi resik|FDMT (4D Molecular Therapeutics, Inc.) - Pangali P/E|lexeotx.com (LXEO) - Periode bali modal bisnis|Pangali P/E KRRO|Koefisien rega marang bathi Editas Medicine, Inc. EDIT|Rasio rega marang bathi silence-therapeutics.com SLN|PRQR: Pangali rega marang bathi|CDXS - Rasio rega marang bathi|Periode bali modal bisnis Sangamo Therapeutics, Inc. SGMO|NAUT (nautilus.bio) - Koefisien rega marang bathi|Kapitalisasi marang bathi Metagenomi, Inc. (MGX)|Koefisien rega marang bathi DTIL|Pangali rega marang bathi GBIO (generationbio.com)|Rasio rega marang bathi Boundless Bio, Inc (BOLD)|Pangali P/E Exicure Inc. (XCUR)|Imunon, Inc. - Koefisien rega marang bathi|PHIO: Pangali rega marang bathi|MBIO - Rasio rega marang bathi|Kapitalisasi marang bathi resik RNAZ|APDN: Pangali P/E|bluebird bio (BLUE) - Pangali P/E|Rasio rega marang bathi ImmunoPrecise Antibodies Ltd.|Kapitalisasi marang bathi Omega OMGA|Pangali P/E OMIC|RGLS - Kapitalisasi marang bathi|Syros Pharmaceuticals, Inc - Koefisien rega marang bathi|Periode bali modal bisnis Codex DNA (TBIO)|TCON - Rasio rega marang bathi|UBX: Rasio rega marang bathi